The advancements in developing a COVID-19 vaccine continue from Rees Scientific customers. Recently, Pfizer and BioNTech announced early positive data from an ongoing Phase 1/2 study of mRNA-based Vaccine Candidate Against SARS-CoV-2.
View the full news release, here.
This post is related to:
Patient Care: Personalized Wellness, Point-of-Care Services Facilities: Temperature Monitoring (Wireless)